On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayJun 12, 2019 10:42 am

Spectrum Global Solutions Inc.’s (SGSI) Bundled Services Strategy Provides Edge in Telecommunications Growth Market

SGSI sees a dynamic market opportunity in new 5G site projects A spike in installation demand combined with limited qualified services firms could result in a financial opportunity for SGSI The company reported positive income from operations during the first quarter of 2019 Spectrum Global Solutions Inc. (OTCQB: SGSI) says that its bundling of services and the low number of qualified services firms in the growing telecommunications market helped drive higher revenues and growth in its margin potential on projects in the first quarter of 2019 (http://ibn.fm/XUSUd). Notably, SGSI reported first quarter revenues of $11,335,732 for the three months ended March…

Continue Reading

WednesdayJun 12, 2019 10:19 am

Earth Science Tech Inc. (ETST) Offers Medical, Industrial Hemp Products as Leader in the CBD Sector

Earth Science Tech is a biotechnology company offering high-grade cannabinoids ETST has diverse subsidiaries that promote the company’s role as a leader in the CBD sector Earth Science Tech has various partnerships and distribution agreements in place Earth Science Tech Inc. (OTCQB: ETST) operates in the hemp cannabinoid, nutraceutical, pharmaceutical and medical device research and development fields. A biotechnology company headquartered in Doral, Florida, ETST markets high purity and quality full-spectrum cannabinoids. The company’s wholly owned subsidiaries – including Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc. and Canna Inno Laboratories Inc. – concentrate on developing Earth Science Tech’s role as…

Continue Reading

TuesdayJun 11, 2019 10:55 am

INmune Bio Inc. (NASDAQ: INMB) Focusing on New Immunotherapies that Reprogram Immune Systems

INmune Bio is at the vanguard of reprogramming the innate immune system for the treatment of disease The company’s focus is on modulating components of the innate immune system to treat cancer and Alzheimer’s disease INmune Bio’s drug candidates include INKmune, INB03 and XPro1595 INmune Bio Inc. (NASDAQ: INMB) is a diversified, clinical-stage biotechnology company headquartered in La Jolla, California. The company is hoping to develop new immunotherapies that reprogram patients’ innate immune systems to allow the immune systems to fight cancer and Alzheimer’s disease. INmune drug candidates INKmune and INB03 may be used to treat cancer, while XPro1595 targets…

Continue Reading

TuesdayJun 11, 2019 10:34 am

Geyser Brands Inc. (TSX.V: GYSR) Moves Forward with Acquisition of Hemp- and CBD-Based Pet and Consumer Health Care Brands

Geyser Brands is entering into a definitive agreement for the acquisition of Solace Management Group for an aggregate purchase amount of $3.9 million The acquisition will enable Geyser to broaden the scope of its CBD- and hemp-based product range, helping solidify its position on the international market Solace has an extensive portfolio of pet and consumer products, as well as licensing distribution and production arrangements Consumer health care company Geyser Brands Inc. (TSX.V: GYSR) recently announced its entry into a definitive agreement for the acquisition of Solace Management Group Inc., a private corporation existing under the laws of British Columbia.…

Continue Reading

TuesdayJun 11, 2019 10:14 am

VPR Brands LP’s (VPRB) Top Line Growth Highlights Scalability Fueled by Capital Infusion

VPR Brands’ quarterly revenues are up by 31 percent The company maintains healthy gross operating margins in excess of 40 percent The e-cigarette/vapor market is estimated to hit $9 billion in 2019 Recent financial results released by VPR Brands LP (OTC: VPRB) show that the multi-brand developer and marketer of nicotine and cannabis products has what it takes to scale up successfully. Revenues for the first quarter of 2019 are up, year-over-year, approximately 31 percent, continuing the trend from the year before, when the top line for 2018 climbed to $4,613,300 and marked a 28 percent increase over 2017 revenues of…

Continue Reading

TuesdayJun 11, 2019 9:52 am

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces C$15M Investment Commitment in Infused Chocolate Production Facility

Anticipating Canadian legalization of adult-use cannabis edibles in October 2019, Organigram recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated chocolate line Production capacity is expected to be about 4 million kilograms per year of exceptional chocolate cannabis edibles The company’s chocolate launch is being led by a product development and production team with more than 25 years of combined chocolate experience and expertise Canada is drawing closer to the legalization of edibles and derivative products, which is expected to occur this fall. As noted by Green Entrepreneur, edibles are expected to increase to 12-14 percent…

Continue Reading

MondayJun 10, 2019 12:07 pm

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases Q1 Results, Begins Trading on OTCQX Best Market

The company maintains the top two best-selling edible cannabis products in California Plus is working to make cannabis safe and approachable for all The company recently reported a 4.9 percent increase in sales over Q4 2018, bringing Q1 2019 retail sales to $10.84 million Plus recently commenced trading on the OTCQX Best Market Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) recently released its unaudited first quarter 2019 results (http://ibn.fm/ZS4tn). As the edibles’ share of the cannabis market continues to grow, PLUS is well positioned to lead the way in the branded products space. The company is one of the fastest-growing brands…

Continue Reading

MondayJun 10, 2019 11:45 am

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Purchases Key Assets, Continues Aggressive Expansion

Innovative Properties officially changed its name to Nabis Holdings Inc. Nabis Holdings continues to pursue investment in high-performing operators in the cannabis industry The company purchased assets from PDT Technologies to expand its production and licensing capabilities Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), a Canadian investment company pursuing interests in high-quality cash-flow assets in real estate, securities, cryptocurrency and all branches of the cannabis sector, has undergone a name change. Nabis Holdings will continue its focus on strategic revenue generation by investing in successful vertically integrated operators. Effective May 6, 2019, the company formerly known as Innovative Properties…

Continue Reading

MondayJun 10, 2019 11:21 am

Hemptown USA Leveraging Leading Genetics to Increase Yields and Expand into Novel Cannabinoids

Hemp seed genetics are critical to hemp farming success Cannabigerol (CBG) is emerging as a valuable cannabinoid with multiple potential health benefits Hemptown USA is growing one million rare cannabigerol-dominant plants designed to yield up to one million pounds of CBG biomass High quality seeds are a key prerequisite for growing healthy, strong cannabis plants. The right seeds can deliver the right cannabinoid profile, increase resilience and help for achieving sufficiently sustainable yields. Companies like Hemptown USA are pioneers in the farming of novel cannabinoid strains in addition to cannabidiol (CBD). In 2019, the company acquired $5.5 million worth of…

Continue Reading

MondayJun 10, 2019 10:55 am

ChineseInvestors.com Inc. (CIIX) Projects Continued Revenue Growth for FY2020

CIIX CEO Warren Wang’s FY2020 projections are driven by forecasts of increased sales of CBD and planned merger/acquisition activities in Asian markets CIIX is also exploring retail space and expanding targeted advertising CIIX’s core revenue source is educational services for the Chinese-speaking investment community, including websites, radio and TV ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang projects that the company’s sales will reach $11-12 million in FY2020, the 12 months ending in May 2020. Wang made the projection in a wide-ranging interview on the Redchip Money Report with host Dave Gentry, broadcast on YouTube (http://ibn.fm/hXpNa). While CBD plays an important role…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered